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ABSTRACT

Bayesian statistical methods are applied to several problems in internal and external
radiation dosimetry. In each case, Bayesian methods produce results that are clear,
coherent (i.e.-following the rules of probability calculus), and free of "ad-hockery" often
associated with alternative frequentist statistical methods.

Research in the area of internal radiation dosimetry focuses on compartmental modeling
of 45 Ca biokinetics. Several approaches are taken to predict compartmental activity at
fixed times. One approach is numerical calculation of the expected value and variance of
compartmental activity using quasi-Monte Carlo integration. This approach considers the
uncertainty of parameter estimates in the calculation, an improvement on the usual
practice of estimating compartmental activity with point estimates of transfer
coefficients. The second approach focuses on the calculation of posterior probability
distributions for the compartmental activities. Predictive densities for observations of
compartmental activity and posterior distributions for expected values of compartmental
activity are calculated for a 2-compartment caternary model with simulated data and for
the

45 Ca

model. The predictive density for an observation is shown to be computable in

all cases, but less desirable than the posterior distribution of the expected value due to
greater uncertainty. The more desirable posterior distribution for the expected value of
compartmental activity cannot be calculated except for extremely simple cases. Instead,
these posterior distributions for the expected value can be approximated using point
estimates of the expectation and variance and an assumption of normality. The final
IV

topic considered in the area of internal radiation dosimetry is compartmental modeling
with missing observations. The general approach of Box et al. (1970) for multiresponse
nonlinear fitting with missing observations is made specific to compartmental modeling.
The method is demonstrated using the 45 Ca biokinetic data by omitting one and two
observations. In both cases, posterior distributions are derived for transfer coefficients as
well as for the missing observations.

Research in the area of external radiation dosimetry focuses on dose estimation with
chromosome aberrations. The topics considered include: chromosome dosimetry for a
single radiation type. for doses received during a criticality accident, with uncertain
calibration doses, and with overdispersed calibration data. The work of Groer et al.
( 1987) for chromosome dosimetry following exposure to a single radiation type is
extended to several new calibration data sets. The results reinforce the practicality and
usefulness of the calibrative density as a tool for chromosome dosimetry. A new method
is developed and demonstrated for chromosome dosimetry following criticality accidents
that permits estimation of the total dose as well as the individual dose contributions from
fission-spectrum neutrons and gamma rays with an imprecise neutron to gamma dose
ratio. This new approach is an improvement over the frequentist methods currently used
for estimating the dose received from a criticality excursion, which rely on an assumption
of precisely-known neutron to gamma dose ratios. Another novel method is developed
for chromosome dosimetry with uncertain calibration doses. It is clear that all doses in
calibration data sets are estimates. and as such they are subject to uncertainty. This
method produces dose estimates that consider the inherent uncertainty of the calibration
V

doses. The last topic considered is model selection/identification. The concerns are the
assumption of Poisson statistics for high linear energy transfer radiations, and the
assumption of a linear dose response for low doses of neutrons. Bayes Factors and
Partial Bayes Factors are used to compare the probabilities of the competing models. The
results show that the Polya model is preferred over the Poisson model for chromosome
dosimetry with high linear energy transfer radiations, and that an assumption of linear
dose response is appropriate for the induction of dicentric chromosome aberrations by
low doses of neutrons.
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CHAPTER 1: INTRODUCTION

1. 1 Background

One fundamental problem faced in all statistical research is how to infer future behavior
from prior knowledge and/or data. The scientific approach to inference, commonly
known as statistics, began in the early to mid-eighteenth century (O'Hagan 1994 ).
Presently, two major statistical schools have emerged and coexist: the classical, or
frequentist school and the Bayesian. Several authors including Lindley ( 1971, 1983 ).
Jeffreys ( 1998), Howson et al. ( 1995), and Savage ( 1972) make convincing arguments for
the Bayesian approach. They show a Bayesian approach yields results that are clear,
coherent, and free of"adhockery" (Good 1959; De Finetti 1974) often found in classical
inference.

The clarity of results is due to the "language" of Bayesian statistics, namely probability
calculus. Uncertainty is described by probability; no other quantity is needed (Lindley
1983 ). Coherence is ensured by strict adherence to the rules of probability calculus. The
axiomatic foundation of probability calculus consists of three fundamental rules:
convexity, meaning that all probabilities must lie between O and 1, with O= impossibility
and 1 = certainty, and the laws of addition and multiplication. All other rules, including
the Bayes Rule, can be derived from these three (Howson et al. 1995).

It is obvious from the ubiquity of classical methods that there is more to the story. The

popularity of classical methods is due partially to the difficulty presented by many of the
calculations required in a Bayesian approach. The price of clarity and coherence is the
considerable computational effort necessary for multidimensional numerical integration
of complicated functions. Historically, such calculations have been virtually impossible,
necessitating the use of approximations that, while ingenious in nature, were necessarily
of unproven accuracy. However, the rapid rise in the availability of computational
resources is easing this burden, sparking a revival of Bayesian methods.

1.2 Purpose and Scope

The general purpose of this research is to explore the application of Bayesian methods for
internal and external radiation dosimetry.

1.2. J External Radiation Dosimetry

The goal of external radiation dosimetry is the accurate estimation or prediction of the
radiation doses received by persons exposed to an external source. Typical sources of
information used in dose estimation include, for example, personal dosimeter readings
and the results of dose reconstruction calculations. Another well-established technique is
chromosome dosimetry, which uses knowledge of the dose response of chromosome
aberrations to make dose estimates. Radiation dosimetry with chromosome aberrations
has the advantage that the dose to cells of an exposed individual can be directly estimated
2

from the response of the individual's cells to radiation and does not have to be inferred by
extrapolation from the response of an external dosimeter. Calibration data are used to
establish the correlation between the number of chromosome aberrations per cell and
radiation doses (Inoue 1995a, b; Lloyd et al. 1979). Following work by Groer et al.
( 1987, 1998), a Bayesian approach is used to generate dose estimates for high and low
doses of neutrons as wells as for x-rays. The so-called calibrative density (Aitchison et
al. 1975) of the unknown dose to an individual is derived for controlled calibration
experiments. This density describes the remaining uncertainty of the final dose estimate
after considering all available information.

A closely related topic is estimating the dose received during a criticality accident. The
situation is more complex than that considered above, since the dose received during such
an accident is due to a combination of fission spectrum neutrons and gamma rays. A new
approach to this problem is developed and applied to experimental data of Voisin et al.
(1997).

An issue that has received little attention in the literature on chromosome dosimetry is

how to account for the inherent uncertainty associated with the doses in calibration data.
The adjective "inherent" is used in recognition of the fact that the calibration doses are
not directly observed, but instead are estimates based on information such as source
strength, geometry, etc. As such, the estimates are subject to error. A novel hierarchical
model approach is used to examine the relationship between calibration dose and the

3

number of chromosome aberrations per cell when both are subject to error. The method
is applied to three different dose response models.

The final topic considered in the area of external dosimetry is model
selection/identification. The concerns are the assumption of Poisson statistics for high
linear energy transfer (LET) radiations, and the assumption of linear dose response for
low doses of neutrons. Bayes Factors and Partial Bayes Factors are used, respectively, to
compare the probabilities of the competing models.

1. 2. 2 Internal Radiation Dosimetry

The goal of internal radiation dosimetry is to accurately estimate the dose delivered by
emitters located inside the body. It is therefore necessary to construct compartmental
models of the biokinetic behavior of internal emitters. Generally speaking,
compartmental modeling refers to any method that seeks to describe a system or process
through a series of interconnected compartments (Godfrey 1983; Jacquez 1972; Anderson
1983 ). It is a diverse area of research with applications in a variety of fields including
chemical engineering, nuclear medicine, health physics, and pharmacology (Gavalas
1968; Welch et al. 1972; Welling 1986). The specific new areas of focus in this
dissertation include Bayesian methods for prediction of compartmental activities and the
impact of missing data on parameter and dose estimates.

4

The first issue considered is a continuation of work by Lo (2000) on the 2-compartrnent
model describing the exchange of 45 Ca between plasma and the bone surface of beagles.
Previously, point estimates of the transfer coefficients were used to estimate
compartmental activities at fixed times. While computationally easier, the use of point
estimates is undesirable, as knowledge of the uncertainty associated with the estimated
model parameters is not considered. In recognition ofthis fact, multidimensional quasiMonte Carlo numerical integration (Wolfram 1996) is used to calculate the expected
value and standard deviation of compartmental activities for fixed times.

The next issue addressed is compartmental modeling with missing data. There are many
reasons why observations might be missed in biokinetic experiments; a Bayesian method
for dealing with this situation is described and demonstrated using the 45 Ca biokinetic
data of Rowland ( 1966). The method is a specific form of the more general approach of
Box et al. ( 1970) for estimation of missing values in multiresponse nonlinear modeling.
Posterior distributions are derived for transfer coefficients and missed observations for
the cases of 1 and 2 missing observations.

The final topic considered in the area of internal radiation dosimetry is prediction of
compartmental activity at fixed times. Consistent with the Bayesian notion that the
probability distribution is the best descriptor of an unknown quantity, two different
approaches are considered. The first method is a reinterpretation of the method used for
compartmental modeling with missing data and yields predictive distributions for
observed values of compartmental activity. The second method is a transformation of
5

variables that produces the posterior density for the expected value of the compartmental
activity. Two different compartmental models are used: a 2-compartment caternary
model with simulated data and the 2-compartment model for 45 Ca biokinetics with the
Rowland data ( 1966). Predictive densities for observations of compartmental activity and
posterior distributions for the expected value of the compartmental activity are derived
for each model.

The remainder of this dissertation is laid out as follows. Chapters 2-5 contain the
external dosimetry research, and Chapters 6 and 7 deal with the internal dosimetry
portion. Chapter 8 contains concluding remarks and recommendations for future work.
References and an Appendix containing computer programs conclude the dissertation.
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CHAPTER 2: THE CALIBRATIVE DENSITY FOR
CHROMOSOME DOSIMETRY

2.1 Introduction

The objective of this portion of the research is to use information on chromosome
aberrations for dose estimation. Chromosome damage and repair following exposure to
radiation are well studied and documented (Bender et al. 1988). One dosimetrically
useful product of radiation damage is the dicentric chromosome aberration, a response
variable of choice for biological dosimetry due to the relative ease with which it is scored
and its low background rate (Moquet et al. 2000). Knowledge of the dose-response for
dicentric aberrations is gleaned from controlled calibration experiments. Speaking in
general terms, a controlled calibration experiment consists of the following steps:
exposing a sample of blood to known doses ofradiation, d; (rad), scoring the number of
dicentrics, Yi, observed in a sample of ni peripheral lymphocytes, and then repeating the
first two steps for i=(l , 2, ... , k) predetermined dose levels. The parameters of the model
assumed to describe the underlying statistical relationship between y, n, and d are then
estimated conditional on the calibration data De = {di, Yi, n;}. The usual assumption is
that y is Poisson distributed with a mean that is either a linear or linear-quadratic function
of d (e.g.- Yi~ Po[n,Bd;] or y; ~ Po[n; (a+Bd;+ yd,2)]).Three different calibration data sets
will be analyzed below, including high and low neutron doses and x-ray doses (Lloyd et
al. 1979; Inoue 1995a, b).

2.2 High Doses of Neutrons

The first data set contains the results of exposing lymphocytes to 0.7 MeV fission
neutrons from the British Experimental Pile Zero reactor (BEPO). This data set is
referred to as the BEPO data set and given by the vectors (Lloyd et al. 1979):

d={50, 75,100,150,200,250,300}
n={269, 78, 115,90,84,59,37}

y={l09,47,94, 114,138, 125,97}

The notation for these vectors follows the naming convention for the subscripted
variables used in Section 2.1. The induced aberration rates are high enough that the
background rate can be neglected. The number of dicentric chromosome aberrations y
observed in a sample of n lymphocytes is assumed to be Poisson distributed with mean
npd. The posterior distribution of the slope parameter p in proportional (ex:) form with a

constant improper prior for pis given as

7

p(PID,) oc

IT (Pd, r· exp{-n,Pd,)

(2.1)

i=I

where De is the calibration data. The marginal density of~ is shown in Figure 2.1. For
dose estimation the calibrative density, discussed by Aitchison et al. (1975), is used. This
density characterizes the uncertainty of the dose estimate conditional on all available data
8

p(~IDc)
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Figure 2.1: Marginal posterior density of p for the BEPO data set
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DA, which consist of the calibration data De and the number of dicentrics, YJ, observed in

a sample of n1 lymphocytes taken from a hypothetical individual exposed to unknown
dose d1. The calibrative density for the case of exposure to high doses of neutrons and a
controlled calibration experiment is given by

p(d 1 JD A) oc p(d1 )

j(n1 Pd1 f

1

exp{-nrPd 1 )p(PJDc )dP

(2.2)

B

p(d1) is the prior density of the unknown dose dr, PWI De) is the posterior density of the

slope parameter, and the remaining terms inside the integrand comprise the likelihood of
a '·future" observation based on the Poisson assumption. Collectively, the integral over
the posterior density of the parameter and the likelihood of a future observation form the
predictive density. For the BEPO data, dose estimates were made assumingy1 = 120 and
n_r = 55. To demonstrate the manner in which ancillary information may be incorporated

into the analysis. a gamma prior with mean of 260 and variance of 100 was assumed for
p(dr), representing a prior estimate of the dose based on TLD readings or maybe dose

reconstruction calculations. The calibrative densities calculated with and without p(dr)
are shown in Figure 2.2.

without p(dj)
withp(d_j}

0.03

0.02

.,,..0.01

-

200

'

/
./

250

'

300

...._

-

350

dr(rad)

Figure 2.2: Calibrative densities for the BEPO data set withyf= 120 and nf= 55,
calculated with and without p(dfl
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2.3 Low Doses of Neutrons

The second calibration data set is from Inoue (1995a) for exposure to low doses of
neutrons from a 252 Cf neutron source. Below this data set is referred to as the 252 Cf data
and given by the following vectors:

d={0.0, 0.2, 0.5, 0.75, 1.0, 2.0}

n={16000, 10000,9300,4660,2477, 708}
y={l0,35, 70,47,39,24}

Unlike the BEPO data set, the doses in the 252 Cf data set and the corresponding aberration
rates are low enough so that the contribution from background must be considered. It is
therefore assumed that the number of dicentric chromosome aberrations y observed in a
sample of n lymphocytes is Poisson distributed with mean n(a+pd), where a is the
background rate. If constant improper priors are assumed for a and

p, the joint posterior

density for the parameters in proportional form is given by:

6

(2.3)

p(a,plD,)oc TI(a+pd,)'' exp{-n,(a+Pd,)}
l=I

Marginal densities may be obtained from the joint density by numerical integration over
the other parameter. Figures 2.3 and 2.4 show the marginal densities of a and
respectively.
12

p,

p(ajDc)

2000

1500

~

1000

~

500

~

0.00025

0.00075

0.00125

a
Figure 2.3: Marginal posterior density of a for the 252 Cf data set
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Figure 2.4: Marginal posterior density of p for the 252Cf data set
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The calibrative density is again used to estimate the unknown dose d1 , resulting in YJ
dicentric chromosome aberrations in a sample of nr lymphocytes. For the

252

Cf data the

calibrative density is given as

p(dl ID A) oc p(dl)

JJn/

1

(a +13dr f

I

exp{-n1 (a +j3d 1 )}p(a, 13IDc )dadl3

(2.3)

BA

p(dr)
is the prior density of the unknown dose dr,
.
. p(a

,Pl De) is the joint posterior density

of the parameters, and the remaining terms inside the integrand represent the likelihood
of a "future'' observation. Dose estimates were made assumingy1 = 25 and n1= 5000 and
a constant prior for d1. The calibrative density is shown in Figure 2.5.

2.4 X-ray Doses

The third calibration data set is from Inoue ( 1995b) for exposure to x-rays. This data set
is referred to below as the X-ray data set and is given by the following vectors:

d={0.0, 0.05, 0. L 0.2. 0.3, 0.4, 0.5. 1.0, 1.5, 2.0}
n={16000,6000,6000.5000,3500,3000, 1674. 1179, 1284, 1325}
y={I0.21.24,36,53,53,34,88. 174,220}

It is assumed that the number of dicentric chromosome aberrations y observed in a
sample of n lymphocytes is Poisson distributed with mean n( a+pd+yd 2 ). Assuming
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Figure 2.5: Calibrative density for the 252 Cf data set with Yt= 25 and n1 = 5000

16

constant improper priors for a,

p, and y, the joint posterior density for the parameters in

proportional form is given by:

10

p( a, p, ylDc) oc

TI (a+ Pd, + yd,2 Y· exp{-n, (a+ Pd, + yd,2)}

(2.4)

I=]

Marginal densities may be obtained from the joint density by numerical integration over
the other parameters. Figures 2.6, 2. 7, and 2.8 show the marginal densities of a,

p, and y

respectively.

The calibrative density is given by Equation 2.5:

p(drlDA) oc p(df)

f ff n
r

1 Y1

(a+Pdr +yd1 2 )Y1 exp{-n1 (a+Pdr +yd1 2 )}p(a,p, rlDc )dru:fpdy

BA

Dose estimates were made assuming Yr= 30, n1 = 1500, and a constant prior for d_r- The
calibrative density is shown in Figure 2.9.
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Figure 2.6: Marginal posterior density of a for the X-ray data set
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Figure 2.7: Marginal posterior density of fJ for the X-ray data set
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Figure 2.9: Calibrative density for the X-ray data set with yf= 30 and nf= 1500

21

2.5 Discussion

Aside from the inherent benefits of coherence and clarity discussed in Chapter 1, the
Bayesian approach to chromosome dosimetry demonstrated above has the particular
advantage over the routine frequentist approaches that diverse sources of information can
be incorporated into the analysis through prior distributions for the parameters and/or the
unknown dose. This is particularly attractive in an area, such as this, where an extensive
body of pertinent information is available for use.
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CHAPTER 3: CHROMOSOME DOSIMETRY FOLLOWING A CRITICALITY
ACCIDENT

3.1 Introduction

The objective of this chapter is to present an approach to dose estimation with
chromosome aberrations following a criticality event. In Chapter 2, a method was
demonstrated for dose estimation with dicentric chromosome aberrations assuming the
dose was deposited by a single radiation type. The situation considered here is more
complex because the total dose received by an individual during a criticality accident will
be from a combination of fission spectrum neutrons and gamma rays. Aside from
estimating the total dose (T) received, it is also desirable to discriminate between the
neutron and gamma ray contributions to T, denoted N and G respectively. As there is no
discernible difference between aberrations induced by gamma rays and those induced by
neutrons. ancillary information must be provided regarding the contributions of each
radiation type to T. In practice this information is expressed in the form of a
neutron/gamma dose ratio, denoted p below, and comes from readings of physical
dosimeters worn by the exposed personnel or from accident dose reconstruction
calculations. Voisin et al. (1997) used frequentist techniques to estimate T, N, and G
under the assumption that p is precisely known. The Bayesian method developed here
allows dose estimation with uncertain p.
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3.2 Method and Data

Experimental results found in Voisin et al. ( 1997) will be used below, including an
estimated neutron/gamma dose ratio of p = 4.76 and post-accident sample results of yr=
100 dicentrics scored in m1 = 34 lymphocytes. For more experimental results and a
detailed discussion of experiments readers are referred to this article.

It is assumed that the number of dicentric chromosome aberrations, y;, observed in a
sample of m; lymphocytes following exposure to high doses of neutrons is Poisson
distributed with a mean that is linear in neutron dose n; (i.e.- y; ~ Po[m,-an;]). For gamma
rays the assumption is thaty; ~ Po[m; (~g;+ yg/}] where g; is the gamma dose. Note that
the background rate is again assumed to be negligible. The model parameters, denoted
collectively by ~ = {a, ~' y}, are usually estimated with data from controlled calibration
experiments. Because the response of dicentrics to radiation is dependent on the dose
rate, the parameter estimates used for dose estimation following a criticality accident
must be based on data from calibration experiments conducted with similar dose rates. In
this analysis, no such calibration data were available. Instead, point estimates of
a=0.835,

p=0.0142, and y=0.0759 (Voisin et al. 1997) were used.

denoted by

!

= { a,

The point estimates,

p, y}, were used to formulate prior distributions for the parameters,

p(a), p(~), and p(y) respectively. Gamma distributions were assumed for the priors, each

parameterized so that E(7ti) =Ai/ </>i = 1 I and Var(1ti) =Ai/ q,/ for i=(l,2,3). As no
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confidence limits for the

i were provided in Voisin et al. (1997), the values assumed for
I

the variances are arbitrary, but sufficient for the purpose of demonstrating the approach.

For dose estimation the calibrative density was again employed. This density
characterizes the uncertainty about T1 , N1, or G1 conditional on all available data DA. In
this analysis, remembering that no detailed calibration data were available, DA consists of
the point estimates and standard deviations for the parameters a,

13, y, p, and the

lymphocytes. Based on the assumption that the
observation of YF
. 100 dicentrics in mF34
.
number of dicentrics, YJ, observed in a post-exposure sample of m1 lymphocytes is
Poisson distributed with a mean of m1 (a ry+/3 gr+y g/), the calibrative density of the
unknown dose t1 is given by

P(/r ID 4 ) oc

ff ff L(a, 13, y, plmr, Yr ,tr )p(a)p(l3)p(y)p(tr )p(p)dadl3dydp

(3.1)

Pf BA

p( u), p(l3), and p(y) are the gamma priors discussed above, p(t1) is the prior density of the

unknown total dose, and p(p) is the prior density for the neutron/gamma dose ratio. The
remaining term inside the integrand, L( a, 13, y, plm 1 , yr, t 1 ), is the likelihood of a future
observation. If p is expressed in terms of the fractional contribution of gamma rays to the
total dose, 0 = 1 / {p + 1), the likelihood term can be written as
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Following analytical integration over a, f3, and y and assuming that p(.tJ) is proportional to
a constant, the calibrative density is given by

where

Calibrative densities for the neutron dose and gamma dose can be obtained from
Equation 3.3 by transformation of variables. The calibrative density for the unknown
gamma contribution. gf, to the total dose is derived as follows:
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3.3 Results

The gamma priors used for p(a), p(~), and p(-y) are shown in Figures 3.1, 3.2. and 3.3,
respectively.

Two analyses were conducted. In the first, the neutron/gamma dose ratio was assumed
precise. In the second, an uncertain ratio was considered by specifying a prior for 0. The
prior of 0 was obtained in two steps. First, a normal prior with mean of 4. 76 and a
standard deviation of 0.5 was assumed for the neutron/gamma dose ratio. p(0) was then
obtained with a variable transformation:

p(0) = p(p(0))1d:~0)1

Figure 3.4 shows the result.

Figures 3.5, 3.6, and 3.7 show comparisons of the estimates oftr, nr, and g,for the two
analyses. The results show that in this case an uncertain neutron/gamma dose ratio leads
to greater uncertainty in the estimates of gr while having no discernible impact on
estimates of tr and n,-
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Figure 3.1: Gamma prior for a based on point estimates from Voisin et al. (1997)
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Figure 3.2: Gamma prior for~ based on point estimates from Voisin et al. (1997)
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Figure 3.3 Gamma prior for y based on point estimates from Voisin et al. (1997)
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Figure 3.4: Prior density for 0 based on experimental results from Voisin et al.
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Figure 3.5: Calibrative density for the total dose t1 withy1 = 100 and n1 = 34
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3.4 Discussion

It is extremely unlikely that the true value of the neutron/gamma dose ratio would be
known precisely following a criticality accident. The Bayesian approach presented above
provides a means for estimating the influence of the uncertainty of this ratio on estimates
of the total dose as well as the neutron and gamma components. This fact, combined
with the ability to incorporate ancillary information and to quantify the uncertainty of
dose estimates probabilistically shows that this approach is an improvement over the
methods currently used to estimate doses after a criticality accident.
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CHAPTER 4: CHROMOSOME DOSIMETRY WITH UNCERTAIN
CALIBRATION DOSES

4.1 Introduction

In Chapters 2 and 3, Poisson models were used to analyze radiation-induced dicentrics in
lymphocytes with the assumption of precise doses in the calibration experiment. In this
chapter, the influence of uncertain calibration doses on the calibrative density is
investigated. In Section 4.2, the method is developed for the simplest dose response
model: linear dependence on dose with negligible background. In Section 4.3, the
method is demonstrated for three different calibration data sets: high doses of neutrons,
low doses of neutrons, and X-ray exposures. The resulting parameter and dose estimates
are compared to those obtained with an assumption of precise calibration doses. Finally.
a discussion in Section 4.4 concludes the chapter.

4.2 Method

This portion of the research benefited from the work of Lindley et al. ( 1966, 196 7) on
functional relationships. Although their error-in-variables models were not employed,
much of their original argument and notation was used. The development begins with a
discussion and reinterpretation of calibration experiments.
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As noted earlier, a calibration experiment consists of the following steps: exposing a
sample of blood to a dose of radiation, ~ ,, scoring the number of dicentrics, y;, observed
in a sample of n, lymphocytes (or genome equivalents (GE), depending on the staining
technique), and then repeating the first two steps for i=(l, 2, ... , k) dose levels. Clearly,
the ~; are not directly observable, instead they are estimated based on information such as
source strength, geometry, etc. In precise dose analyses these estimates of the true doses
~

;, denoted !;, are assumed to be equal to the true doses. Below, hierarchical models are

used to account for the uncertainty about ~ ;.

The simplest example of a relationship between the number of aberrations, 11, the number
oflymphocytes scored, n, and dose~ (rads) is given generically by

(4.1)

The development is limited to this simplest model to minimize the complexity of the
notation and expressions. It is assumed that y; is an observation of 11,, Poisson distributed
with mean 11, = n, 0 ~;. The true doses,~;, are treated as parameters having priors, denoted
p(~;), with E(~;)= t; and Var(~i) = r/. Uncertainty with regards to the discrepancy

between a particular ~' and its estimate I; can be accounted for by numerical integration
over r,, referred to as a hyperparameter, where the range of integration reflects beliefs
about the smallest and largest credible discrepancies.
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The parameter 0 is usually referred to as "structural" since it appears in the likelihood of
all the observations, and the

~i,

and

'ti

are labeled "incidental" as they are associated with

a particular {y;} only. The incidental parameter vectors will be denoted by ; = {~1,

/;],

... , l;,i}and T = {-r1, 't2, ... , 'tk}. Similarly, the notation t = {ti, t2, ... , tk} and n = {n,, n2,
... , nk} is used for the estimated doses and lymphocytes scored. The following

assumptions are made:

p(0,T) = p(0)p(T) oc constant

(1)

(2) the I;,, given t and T, are independent:
k

p(;lt, T) = TI P<s,lt, T)
i=I

( 3) for a given t; and

't ;, /;;

is independent of all t1 and t 1 with j

i- i

PCs, It, T) = p(s, Ir,, t,)
(4) they;, given ;, 0, and n, are independent:
k

p(yj;. 0, n) = TI p(y, I;, 0, n)
i=I

(5) for a given/;;, 0, and n,, y; is independent of all~ and n1 with j
p(y, j;. 0, ")

i- i

= p(y, Is,, e.n,)

For the analyses to follow in Section 4.3, the p(/;;) were assumed to have gamma
distributions parameterized such that E(I;;)= I;= A; Ip; and Var(/;;)= -r, 2 = "A.;lp/. Gamma
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distributions were used for computational convenience. They permit analytical
elimination of the s,, and are flexible enough to permit expression of a wide variety of
prior opinions. Numerical values for A; and p; were calculated by solving E(s;)= t; = l;I p;
and Var(s;) = (o-/3)2 = l;/(p;)2, for A; and p;, where I;± cr; corresponds to an approximate
99% probability interval for

Si•

Using these distributional assumptions and (1 )-(5) from

above, the posterior distribution of 0 can be constructed and the incidental s's eliminated
as follows

(by assumption (I))

f

oc p(yj;, 8. n)p(;jt. l, p)d;

k

oc

fTI p(y, j;, 8. n)p(s, It, l, p)d;

(by assumptions (2) and (4))

::;: i=I

TI f(8s, f' exp{-n,8s, }('_, exp{-p,s, }ds,) (by assumptions (3) and (5))
k

oc

"'

1=1 O

TI (8 fs;',+).,-I exp{-s, (n,8 + P, )}ds,)
k

oc

"'

1'

i=I

oc

O

+ 11, ,)
TI_ (n8''8r(y
,
+ p )y,+).,
k

l-1

I

(4.2)

I

For dose estimation the calibrative density was again used. This density characterizes
here the uncertainty about 'E.rconditional on all available data DA, which consist of the
calibration data D, and the number of dicentrics. YJ- observed in a sample of n1
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lymphocytes. or GE, taken from a hypothetical individual exposed to an unknown dose
3 1. The calibrative density for a controlled calibration experiment is given by:

p(~ r

ID A) oc p(~r) fp(yr lnr, ~f, 0)p(0ly, n, t, l, p)d0

(4.3)

0

p(~r) is the prior density for 31, DA=Dc +{y1I n1}, p(y I Inf ,t1 ,0) is the Poisson likelihood

for a future observation, and p(0ly, n, t, l, p) is the posterior density of the parameter
from Equation 4.2.

4.3. Examples

./. 3. I High Neutron Dose Data

The first calibration data set analyzed, denoted D8 , is from Lloyd et al. (1979) for
exposure to 0.7 MeV fission neutrons from the British Experimental Pile Zero reactor
(BEPO). The data consist of calculated dose values, ti (rad), the number of lymphocytes
scored, n,. and the number of dicentric chromosome aberrations observed, Yi· D 8 is given
by the vectors

t={50, 75, 100,150,200,250 300}
n={269, 78, 115,90,84,59,37}
y={ 109, 47, 94, 114, 138, 125, 97}
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The distributional assumptions made were: y; ~Po[n; ~~i] and p(~;)~Ga[A.,, p,]. The A., and
p; were calculated by assuming approximate 99% probability intervals for the doses of 50
± 30, 75 ± 40, 100 ± 52.5, 150 ± 67.5, 200 ± 75,250 ±75, and 300 ± 67.5 (rads). Note

that these probability intervals are only used for demonstration and do not necessarily
reflect the dose uncertainty in the original published experiments. The resulting values
are given by the vectors

l = {25, 28.70, 32.65, 44.44, 64, 100, 177.77}
p = {0.5, 0.38, 0.33, 0.30, 0.32, 0.4, 0.6}

Figure 4.1 shows the p(~;).
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Figure 4.1: Gamma priors for the true doses (BEPO data)
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The posterior density for the slope parameter p in proportional form was derived as
follows

Jll (Ps, f' exp{-n;Ps;}s,',-I exp{-P;S, }~
6

p(PJi, p, DB) 0C

::::

oc

/=]

6

co

l=I

o

Il (pv, Js;V,+A,-1 exp{-~,(n;p+p,)}~,)
(4.4)

Figure 4.2 shows a comparison of the marginal densities for

p for precise and uncertain

doses.

In the dose estimation example it was assumed that Y1= 64 dicentrics were observed in nr
=I 04 scored lymphocytes of the accident victim. The calibrative density is given by

p(sr IDA) oc p(sl) J(Psr }'' exp{-nrP~r }p(PI"-, p, DB )dp

(4.5)

B

DA=Ds+{yrl nr},p(sr) is assumed constant, and p(Pll,p, DB) is from Equation 4.4.

Figure 4.3 compares the calibrative densities for precise and uncertain calibration doses.

s

The influence of calibration dose uncertainty on 1 was small in this case.
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Figure 4.2: Marginal Densities of p for the BEPO data
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Figure 4.3: Calibrative densities for the BEPO data set with Yt = 64 and n1= 104
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4.3.2 Low Neutron Dose Data

The second calibration data set analyzed, denoted Di, was from Inoue (1995a) for
exposure to low doses of neutrons from a 252 Cf neutron source. The vectors comprising

D1 have descriptions analogous to those previously given for the high neutron dose data.
D1 is given by the vectors

t={0.0, 0.2, 0.5, 0.75, 1.0, 2.0}
n={16000, 10000,9300,4660,2477, 708}
y={l0,35, 70,47,39,24}

The distributional assumptions made were thaty1 -Po[n;(a+~~1)] andp(~;)-Ga[A1, p,]. The
A; and p, were calculated by assuming approximate 99% probability intervals for the
doses of0.2 ± 0.2, 0.5 ± 0.45, 0.75 ± 0.6, 1.0 ± 0.7, and 2.0 ± 1.0 (rads). Note that the
zero dose level was assumed precise. The results are given by the vectors

A={0. 9.0, I 1.11, 14.06. 18.37, 36.0}
p={0, 45.0, 22.22. 18.75, 18.37, 18.0}

The first element in both vectors is a dummy entry that accounts for the assumption of a
precise zero dose level. The p(~,) are shown in Figure 4.4:
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Figure 4.4: Gamma priors for the true doses (252 Cf data)

The joint posterior density for the parameters a and

p in proportional form was derived as

follows

p(a,

Pl"-, p, DI) 0C a

fIT (a+ P~, r, exp{-n, (a+ P~, )}('_, exp{-p,~, }~
6

Y,

exp{-n1a}

= 1=2

(4.6)
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Analytic forms of the marginal densities for a or ~ were obtained by integrating over the
other parameter. The marginal densities in proportional form are given by

(4.8)

Figures 4.5 and 4.6 show the marginal densities for precise and uncertain doses. There
was a slight difference in the posterior densities of a, and a more pronounced difference
in the posterior densities of~-
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Figure 4.5: Marginal densities of a for the
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252 Cf data
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Figure 4.6: Marginal densities of pfor the 252 Cf data set
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0.0225

For the dose estimation example it was assumed thaty1= 25 dicentrics were observed in

nr=5000 lymphocytes of the accident victim. The calibrative density is given by

p(s1IDA) oc p(s/)

JJ(a +f3sr fl exp{-nr(a+f3sr )}p(a,f3ji,p,D, ')dadf3

(9)

BA

D,.i=D1+{yrl n1},p(9) is assumed constant, and p(a,~ji, p, D,) is from Equation 4.6.
Figure 4.6 compares the calibrative densities for precise and uncertain doses. The
influence of dose uncertainty on srwas again found to be small.
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Figure 4.7: Calibrative densities for the 252Cf data withy1 = 25 and n1 = 5000
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4. 3. 3 X-ray Calibration Data

The final calibration data set analyzed, denoted DF, was from Bothwell et al (2000) for
exposure to X-rays generated by a Seiffert therapeutic X ray machine. The vectors
comprising the data set are analogous to the vectors given for the two previous data sets
except that the ni represent the number of GE rather than the number of lymphocytes
since fluorescent in situ hybridization (FISH) was used. DF is given by the following
vectors
t={0.0, 33.5, 65.8, 98.8. 196.1}
n={424,409,328,341,239}
y={0,9,21,44, 105}

The distributional assumptions made were that y; ~Po[ ni( a+~~i+y~?)] and p(~i)~GaP-i, pi].
The "A, and Pi were calculated by assuming approximate 99% probability intervals for the
doses of 33.5 ±33.5, 65.8 ± 59.22, 98.8 ± 79.04. and 196.1 ± 117.6 (rads). The results
are given by the vectors

J...= {0. 9.0, I I.I I, 14.06. 25.0}
p= {0.0.27,0.17,0.14,0.13}

Note that the zero dose level was again assumed precise and that a dummy entry was
inserted into the first position of both vectors. The p(~,) are shown in Figure 4.8.
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Figure 4.8: Gamma priors for the true doses (FISH data)
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350

The incidental

~i

were eliminated and the joint posterior density of the parameters derived

as follows:

p(a, P,

YI'-, p, Dr) oc fa
-

5

Y,

e-n,a

TI p(y I;, a, p, y, n; )p(;lt, I., p)d;
1

1=2

In (a+ p~I + y~; y, exp{-nl (a+ p~I + y~; )5

oc aY' e-n,a

P1~1 } ( ' ~ I ~

:::: 1=2

where

(n 1P+p 1 )r(j+m+A, +l)<l>(j+m+'A, 1 +I .l, (n 1p+p 1 )2 JJ
2

2

2

<l>(a.b.c) represents the confluent hypergeometric function.
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4n y
1

(4.10)

The joint posterior density of~ and y was obtained by analytical integration over a:

The complexity of Equations 4.11 and 4.12 forced the use of quasi-Monte Carlo
numerical integration (Wolfram, 1996) of Equation 10 over B and the appropriate
structural parameters instead of using Equations 4.11 and 4.12 directly to obtain marginal
densities for a,~- and y. Figures 4.9, 4.10, and 4.11 compare the marginal densities for
precise and uncertain doses.
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Figure 4.9: Marginal densities of a for the FISH data
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Figure 4.10: Marginal densities of JJ for the FISH data
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Figure 4.11: Marginal densities of y for the FISH data
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0.000025

There was little difference in the marginal densities of a, but distinct differences between
the marginals for~ and y. In the dose estimation example for DF it was assumed thaty1=
35 dicentrics were observed in n1=330 GE. The calibrative density conditional on the
available data, DA= Dp{yJI n1}, with a constant prior p(sr) is given by

p(~, jDA) oc

ff f(a+ P~r + y~} )"r exp{-nr (a+ P~

1 +

y~} )}p(a, p, rll, p, D,. )dadpdy

rBA

p( a,

p, rll, p, DF)

is given by Equation 4.10 and all integrations were again performed

numerically with quasi-Monte Carlo integration. Figure 4.12 compares the calibrative
densities for precise and uncertain doses. In this case the calibration dose uncertainty
significantly increased the uncertainty of the dose estimate.

4.4. Discussion

The approach presented above provides a framework for evaluating the influence of
imprecise calibration doses on parameter and dose estimates. As is the case with any
hierarchical approach, different distributional assumptions about the p(~;) can be made.
The analytical expressions obtained for posterior distributions of the parameters based on
the assumption of gamma distributions for the p(~;) were a convenient starting point for
such an analysis.
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Figure 4.12: Calibrative densities for the FISH data withy1 = 35 and n1 = 330
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CHAPTER 5: MODEL COMPARISON USING BAYES FACTORS AND
PARTIAL BAYES FACTORS

5.1 Introduction

The selection of an appropriate model is critical for good inference. This portion of the
research focuses on model comparison and selection from a Bayesian standpoint. The
Bayesian approach to model comparison is well known (O'Hagan 1994; Kass 1983):
given two competing models. m 1 and m2 , the probabilities of the models conditional on
the same data Dare compared. This idea is expressed mathematically as follows

I D)
p(m2 I D)
p(m1

p(D
p(D

I m1)
I m2)

p(mi)

(5.1)

p(m2)

The term on the left is the posterior odds ratio, the first right-hand term is the Bayes
Factor (BF). and the second right-hand term is the prior odds ratio. If no preexisting
preference for either model exists, the prior odds ratio is set to l and the posterior odds
ratio is then equal to the BF. This factor updates the probability that either model is
valid. The BF for models 1 and 2 is given by

p(D!m,)
=-------

p(Dlm2)

fL(02 ID)p(02 )d02

('-)'
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(5.2)

L(8 1 ID)= Likelihood for parameter vector 8 1 given data D

where

L(8 2 ID)= Likelihood for parameter vector 82 given data D
p(8;)= joint prior distribution for parameter vector 8; (i= 1,2)

Note that the p(8;) are needed to calculate the BF. O'Hagan (1994) describes in detail the
potential difficulty associated with use of the BF when there is weak prior information
available regarding the p(8;). In particular, improper priors may lead to infinite values for
the BF, and the BF may be sensitive to the ranges of proper uniform priors. One method
for dealing with weak prior information is known as Partial Bayes Factor (PBF)
(Lempers 1971; O'Hagan 1994). Assuming that the data are divided into two groups y
and z, where y is the training data, the PBF is given as

(5.3)

PartialBayes Factor = p(z_l ~i,y)
p(_z I m2,y)

which is the ratio of the marginal densities of the data z for models l and 2 based on
posterior densities p(8;j y). The marginal densities are given by

p(zl m,.y)= JL(O,lz)p(O,I y)d8,

(5.4)

<➔

where
L(8,j z)
p(8;j y)

= likelihood for parameter vector 8; given data z

= joint posterior density for parameter vector 8; given training data y
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The result of the integrations required by Equations 5.2 and 5.3 will be a numerical value
representing the ratio of two probabilities. The logarithm of this value is referred to as
the "weight of evidence" (Good 1983). Some authors, including Jeffreys (1998) and
Turing as quoted in Good (1983), choose to interpret the weight of evidence on the log10
scale. For example, Jeffreys ( 1998) considers log 10(BF)>O.5 as "substantial" evidence,
log 10(BF)> 1 as "strong" evidence, and log 10(BF)>2 as "decisive" evidence. Note that
when discussing the interpretation of numerical values, the results apply to both the BF
and the PBF.

The coin-tossing analogy of Good ( 1959) serves as a convenient device to calibrate one's
interpretation of the BF (or PBF) and the corresponding weight of evidence. Suppose a
coin is thought to be either fair or double-headed, designated by M1 and M 2 respectively.

If both models are assumed to be equally probable, i.e.- p(M1 )and p(M2 ) = l /2, the prior
odds ratio is 1 and the posterior odds ratio equals the BF. Suppose now that the coin is
tossed ten times, each toss resulting in heads. The BF is then given by

p(DIM1)
p(DIM2)

1 1 1 1 1 1 1 1 1 1
-x-x-x-x-x-x-x-x-x=

2 2 2 2 2 2 2 2 2 2
Ixlxlxlxlxlxlxlxlxl

1

1024
1

1
1024

=--=--

Thus, the probability that the coin is double-headed, given ten heads in a row, is 1024
times greater than the probability that the coin is fair. meaning that the probabilitygiven the data - of the coin being double-headed is 1024/1025. Note that neither this
example nor the practices of Jeffreys and Turing are intended to create rigid standards for
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interpreting the BF, but instead to provide "a rough descriptive statement about standards
of evidence in scientific investigation" (Kass, 1993 ). The unique requirements and
circumstances of the particular analysis must be considered when interpreting the value
of BF.

As noted in Chapter 1, the BF and PBF were applied to two problems in chromosome
dosimetry. In the next section, the BF is used to analyze the occurrence of so-called
overdispersed data from calibration experiments involving high LET radiations.
Comparisons are made between parameter and dose estimates calculated under the
assumption of two competing models. In the final section, the PBF is used to compare
two different Poisson models as descriptors of calibration data for experiments involving
low doses of neutrons. A Poisson model with a linear mean, the accepted model, is
compared to a Poisson model with a linear quadratic mean.

5.2 The Polya Model for Overdispersed Calibration Data

5. 2.1

Introduction

To review, a controlled calibration experiment consists of three steps: exposing a sample
of blood to known fixed doses of radiation, d;, scoring the number of dicentrics, y;,
observed in a sample of n; peripheral lymphocytes, and then repeating the first two steps
for i=(l, 2, ... , k) dose levels. The parameters of the model assumed to describe the
underlying statistical relationship between y, n, and dare then estimated conditional on
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the calibration data De = {d;, y;, n;}. The usual assumption is that y is Poisson distributed
with a mean that is either a linear or linear-quadratic function of d (e.g. y; - Po[ n;(a+ BdJ]
or y; - Po[n,{a+0d;+ yd/)]. It is however known that data from calibration experiments
involving high LET radiations can be "overdispersed" (Lloyd et al. 1979). In the present
context, overdispersed refers to discrete random variables that have a variance greater
than their mean. Frequentist statistical methods are routinely used to identify and account
for overdispersion in data from calibration experiments (Rao et al. 1956; Lloyd et al.
1979; Jin et al. 1998). Here a Bayesian approach is taken to parameter and dose
estimation when overdispersion is suspected. The Bayesian treatment introduces a new
modeL the Polya (Arley 1943) or negative binomial (Johnson 1969) model. This model
is characterized by an additional parameter, labeled 'I' below, which measures the degree
of overdispersion. The BF will be used to weigh the evidence in support of the Pol ya
model as compared to the alternative Poisson model. Bayesian methods will also be
employed to derive dose estimates for hypothetical radiation accidents under both
Poisson and Polya model assumptions, allowing the impact of different model choices to
be evaluated.

5.2.2 Method and Data

Two different calibration data sets will be used. Both are from Lloyd et al. ( 1979) and
consist of the number of dicentric chromosome aberrations, y;, observed in a number of
peripheral lymphocytes, n,. after exposure to a known dose, d, (rad). The first data set
contains the results of exposure to 0.7 MeV fission neutrons from the British
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Experimental Pile Zero reactor (BEPO). This data set will be referred to as the BEPO
data set and is given by the vectors

4={50, 75,100,150,200,250,300}
n={269, 78, 115,90,84,59,37}
y={l09,47,94, 114,138, 125,97}

The notation for these vectors follows the naming convention for the subscripted
variables introduced in the previous paragraph. The second data set describes the results
of exposure to 14.7 MeV neutrons from D-T reactions. This data set will be referred to
as the D-T data set and is given by the vectors

g={5, 10,25,50, 101,152,202,303}
n={2000, 763, 723,568,472,303,243,67}
y={34,25,50,65,202,202,206, 100}

Assuming the number of dicentrics y to be Polya distributed with mean n0d results in a
probability density function (Arley 1943) given by

f(yjn, d, e, \Jf)

1
= ( _..!_J (-\Jf )''( -n0d
-]y (1 + \jln0dt;
\j/

1+ \jln0d

y
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(5.5)

where 'V 2 0, 0 2 0, and the variance of y is n0d( 1+'Vn0d). It can be seen that in the limit
\V ➔O

the Polya model collapses into the Poisson model (Arley 1943). Alternatively, for

'V > 0 the ratio of the variance to the mean will be greater than one, indicating a Pol ya

model. The implications of the Polya model for the mechanism of induction of di centric
aberrations are not discussed here. It is noted that violation of one or more of the
independence assumptions required for Poisson behavior is often cited as the source of
overdispersion (Johnson 1969; Jeffreys 1998)

In Section 2.2.1, calibrative densities were used to demonstrate the Bayesian approach to
dose estimation after neutron exposures based on the assumption of a Poisson model.
The salient features of the analysis are briefly repeated below as they pertain to the Pol ya
model. The joint posterior density of the parameters in proportional ( oc) form with
constant priors for 0 and 'V is:

(5.6)

k being the number of dose levels. Numerical integration of p(0,\V IDe) over one of the
parameters yields the marginal density for the other parameter.
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For dose estimation the calibrative density, discussed by Aitchison et al. (1975), was
employed again. The calibrative density for the Polya model and a controlled calibration
experiment is given by Equation 5.7:

JJ(..d1) is the prior density of the unknown dose d1, JJ(..0, 'I' I De) is the joint posterior density

of the parameters (Equation 5.6), and the remaining terms inside the integrand comprise
the likelihood of a "future" observation based on Equation 5.5. For the BEPO data, dose
estimates were made assumingy1 = 120 and n1 = 55. The dose estimates for the D-T data
were based on Y1= 400 and nr= 500.

The posterior odds for model comparison, discussed in the previous section, adapted to
current circumstances is

p(PolyaiD,)
p(PoissonlD,)

=

p(Dc!Polya)

p(Polya)

p(DclPoisson) p(Poisson)

(5.8)

Again, the term on the left is the posterior odds ratio, the first right-hand term is the
Bayes Factor (BF), and the second right-hand term is the prior odds ratio. No preexisting
preference is assumed for either model. i.e. the prior odds ratio is set to 1, and the
posterior odds ratio is then equal to the BF, given here by
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<Xl<Xl

<Xl

(5.9)

JL(0jDJp(0)d0
0

where
L(0, 'lf!Dc) is the Polya likelihood

L(0jDc) is the Poisson likelihood given calibration data De.

The proper prior distributions for the parameters are denoted by p(0,'V) and p(O). A
priori, the parameters 0 and 'V are assumed to be independent i.e. p(O,'V) = p(0) p('lf).
Note that p(O) stands for different distributions in the numerator and denominator of
Equation 5.9 since, as always, distributions are labeled by their arguments. p(O) and
p('lf)were constructed using published information regarding dose-response parameters
for di centric chromosome aberrations. The sensitivity of the BF were assessed by using
several different combinations of prior distributions. Differences in experimental
conditions, particle energy, etc. were accounted for by increasing the standard deviations
of the prior distributions.

For the analysis of the BEPO data set, one proper uniform (U) and three normal (N)
priors for the slope parameter were derived using published estimates of e and its
standard error (0 = 0.0087 ± 0.0003) for exposure to 0.85 MeV neutrons (Lloyd et al.
1975). The priors used are p(8) - U[0.0087± Sx 0.0003] and p(8) - N[µ,cr 2 ] with µ =
0.0087 and cr = {2x 0.0003, 3x 0.0003, 5x 0.0003}, respectively
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Figure 5.1: Normal priors for the slope parameter 0 for the BEPO data

Likewise. three gamma priors for '-I' were derived using published expert opinion that
values of 1.1 or 1.2 are appropriate as the ratio of the variance to the mean for calibration
experiments involving neutrons (Lloyd et al. 1983). The priors used were p(\jl) ~ Ga[a,

p] with a = {1, 2, 5} and P= {10, 10. 50}, respectively.

The gamma distributions.

parameterized so that E('-1') = a Ip and Var(\j/) = a I p2• are shown on Figure 5.2:

The prior distributions used in the analysis of the D-T data set are obtained from posterior
distributions derived from Poisson and Polya likelihoods with the data of Sasaki et al.
( 1971) for a calibration experiment involving 14.0 MeV neutrons.
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Figure 5.2: Gamma priors of \j/ for the BEPO data

This data set will be referred to as the Sasaki data set, denoted by Ds, and is given by the
vectors

g={ 15. 21. 42. 82. 124. 165,248.329. 428,660}

n={ 1511. 1198, 500,305. 500. 500,277. 308,200, 30}
y={l5.46,44,88,208.293.239,315,330,84}

The data for the zero dose level were not considered since the aberration rates at all dose
levels are large enough to make the background rate negligible. The posterior densities
obtained from the Sasaki data set were used to calculate expectations and standard
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deviations for the parameters, from which prior distributions were determined as
described below. The posterior expectations and standard deviations are:

E(01Ds)Po = 0.0032; SD(01Ds)Po =7. 928x 10-5
E(01Ds)PI = 0.0032; SD(01Ds)PI =6.042x 10-4
E('VIDs) = 0.3187; SD(\VIDs)=0.1882

The subscripts indicate the model used for the likelihood. Two proper uniform and four
normal priors were used for the slope parameter 0. They are p(0) ~ U[0.0032

± 5x

7.928x10" 5], p(0) ~ U[0.0032 ± 5x 6.042x10-4], andp(0) ~ N[µ;,cr;2] withµ;= 0.0032 and

cr, = {2x 7.928x10- 5 , 4x 7.928x10·5 , 2x 6.042xl0-4, 4x 6.042x10-4) for i=(l. 2, 3. 4).
The normal priors are shown in Figure 5.3:

Three gamma priors were used for 'V, given by p(\V) ~ Ga[a,
and

P] with a= {1.0, 1.6, 2.9}

p = {3.125, 5, 9}, respectively. The priors are shown in Figure 5.4.

The ranges of values for the BF and the weight of evidence, resulting from different
combinations of the above priors, are given in the Results section below.
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Figure 5.3: Normal priors for the slope parameter 0 for the D-T data
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Figure 5.4: Gamma priors of 'I' for the 0-T data
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1.2

5. 2. 3 Results

BEPOdata
The values of the BF for different combinations of the prior distributions listed in Section
5.2.2 range from 0.0022 to 0.0037, indicating support for the Poisson model. The
corresponding range for weight of evidence is -2.66 to -2.43. Referring to the cointossing example of Good, the BF of 0.0022 (representing the least support for the Polya
model) equates the probability of the Polya model being the best descriptor of the BEPO
data to the probability of a fair coin producing between 8 and 9 heads in a row in as many
tosses. Figures 5.5, 5.6, and 5.7 reveal only slight differences between Poisson and Polya
parameter and dose estimates. This is expected given the marginal density of 'I' seen in
Figure 5.6 and the fact that the Polya model collapses into the Poisson model as

\11 ➔0.

D-T data

The values of the BF for several different combinations of the prior distributions listed in
Section 5.2.2 range from 8221.5 to 12802.9, indicating support for the Polya model. The
corresponding range for weight of evidence is 3.91 to 4.11. The smallest value of the BF,
8221.5, again representing the least support for the Polya model, equates the probability
of the Poisson model being the best descriptor of the D-T data to the probability of a fair
coin producing 13 heads in a row in as many tosses. The results of parameter and dose
estimation shown in Figures 5.8. 5.9, and 5.10 reveal significant differences between the
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two models. Especially striking is the increased dispersion of the calibrative density seen
in Figure 5.10, which indicates greater uncertainty about dr.

From the results it is clear that the Polya model is a better descriptor of the D-T data, and
provides results differing little from those obtained with the Poisson model for the BEPO
data. The additional computational burden incurred by considering the parameter 'V is
small. Considering this computational feasibility, the fact that the Polya model collapses
into the Poisson model as 'V goes to zero and the potential discrepancy between the Polya
and Poisson based dose estimates (see Figure 5.10 for example), it is clear that an initial
assumption of a Polya model is the preferred and conservative approach to chromosome
dosimetry for high LET radiations.

5.3 Partial Bayes Factor for Comparing Linear and Linear Quadratic Poisson
Means

5. 3.1 Introduction

In Section 2.2.2 Bayesian methods were used to provide parameter and dose estimates for
exposure to low doses of neutrons under the assumption that the mean of y is linear in
dose. i.e. y- Po[n (a+0d) ]. While this assumption is consistent with the current practice
in chromosome dosimetry. plots using approximate 99% probability intervals for the
linear. shown in Figure 5.11. and linear quadratic fits (i.e. y- Po[n(a+~d+yd 2 )]), shown in
Figure 5 .12. seem to suggest that the latter may the better choice.
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f3 for the BEPO data set
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252 Cf data
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Figure 5.12: Linear-Quadratic Fit to the 252 Cf data

5. 3. 2 Method

Assuming no prior preference for either model, the posterior odds ratio is equal to the BF:

p(lineariD,)

p(lin.quad.jD,)

=

p(D,llinear)

p(D,llin.quad.)
-:r:. oc

0 ()

=------------

ff fL(a, p, yjD, )p(a, p, y)dadpdy

0 0 0

where

L( a. PID,) = likelihood for the linear model
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(5.10)

L(a, J3, ylDc) = likelihood for the linear quadratic model

In this case, none of the usual sources of prior information such as similar data from other
calibration experiments involving low doses of neutrons are available. Therefore, the
PBF will be used to circumvent the lack of prior knowledge. Assuming the calibration
data are divided into two groups r and s, where s is the training data, the PBF is given by

p(rllinear.s)
PBF=-----p(rilin.quad.,s)
00 00

ff L(a,J3lr)p(a,J3is)dadJ3

0 0

=------------00 00 00

ff fL(a, J3, ylr) p( a, J3, yls )dadJ3dy

(5.11)

0 0 0

Two different divisions are used below. ln the first, sis comprised of the first two dose
levels, and r consists of the last four. The second division takes the first three doses
levels for s. leaving the last three for r.

5.3.3 Results

For the first division of the calibration data. PBF = 12.13. The corresponding value for
the weight of evidence is 1.08. Referring to the coin-tossing example of Good. the PBF
of 12.13 equates the probability of the linear-quadratic mean being the best descriptor of
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the data to the probability of a fair coin producing between 3 and 4 heads in a row in as
many tosses. For the second division of the calibration data, PBF = 2.07. The
corresponding value for the weight of evidence is 0.32. Referring again to the cointossing example of Good, the PBF of 2.07 equates the probability of the linear-quadratic
mean being the best descriptor of the data to the probability of a fair coin producing 1
head in as many tosses. The conclusion is that there is no compelling evidence to
abandon the standard assumption of a mean linear in dose in favor of a mean linear
quadratic in dose for describing the induction of dicentric chromosome aberrations by
low doses of neutrons.
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CHAPTER 6: COMPARTMENTAL MODELING OF 45 Ca BIO KINETICS

6.1 Introduction

The objective of this chapter is to continue the work of Lo (2000) on the 2-compartment
3-parameter model describing the exchange of 45 Ca between plasma and bone surface in
beagles. The compartmental model, data, and distributional assumptions are presented in
Section 6.2. In Section 6.3, numerical integration is used to calculate the expected value
and standard deviation of compartmental activities at different times. In Section 6.3, a
method is demonstrated for compartmental modeling with missing observations. The
chapter concludes with a discussion in Section 6.4

6.2 Model and Data

The 2-compartment model representing the exchange of 45 Ca between the bone surface
and the plasma is shown in Figure 6.1.

a

y

Bone Surface

Plasma

/3
Figure 6.1:

45 Ca

compartmental model
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►

The activities at the bone surface and in the plasma at time tu are denoted a 1(tu, 0) and
a2(tu, 0) respectively where 0 = {a,

13, y}.

The parameters a,

13, and y are the transfer

coefficients for the compartmental model and represent the rate at which activity enters
or exits the two compartments. The average movement of the 45 Ca activity is described
by the following set of differential equations:

da (t,0)
dt

- 1- - = -aa 1 (t,0) + pa

1

-

(t,0)

da 1 (t, 0)
-dt = aa 1 (I.
0) - pa, (t, 0)-ya, (t, 0)
.
-

(6.1)

(6.2)

Subject to initial conditions of a 1(O, 0)=0 and a 2(O, 0)= ao, the following solutions for
Equations 6.1 and 6.2 were obtained using the method of eigenvalues (Jacquez 1985):

where
),1

= -¾(ca+p+y)+.J(a+p+y) 2 -4ay)
"-
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A2

=-

~ (( a + ~ + y) - .J(a + ~ + y) 2 -

4ay )

The solutions are the expectation functions for the time-dependent compartmental
activities.

The data are from Rowland et al. ( 1966) and consist of ten timed and paired observations
of 45 Ca specific activity at the bone surface, denoted y 1, and in the plasma, denoted Y2The data are listed in Table 6.1.

Table 6.1:

Time (hours)

45 Ca

biokinetic data from Rowland et al (1966)

Compartment Activity (µCi/mg

45 Ca)

(tu, u=0:10)

Bone Surface
(yi)

(y2)

0.0

0.00

27.1

0.2

1.10

22.0

0.52

2.81

17.0

1.0

3.39

15.0

2.0

3.53

14.0

4.0

4.37

9.5

6.0

4.89

8.0

24.0

5.79

5.0

48.0

4.16

2.3

120.0

1.97

1.3

408.0

0.21

0.1
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Plasma

The observed activities at time lu are denoted Yu= {Yiu, Y2u} and assumed to be normally
distributed with means a 1(tu, 0) and a2(/u, 0) respectively. The error associated with an
observation Yiu is denoted Eiu, and given by

(6.5)

The errors are assumed to come from independent multi variate normal distributions with
E(Eiu)=0, E(Eiu Ejv)=O for u:;t:v, and E(Eiu Eju)=aij, The variance covariance matrix is
denoted L, and it's inverse by A:

and

6.3 Calculation of the Expected Value and Standard Deviation of the
Compartmental Activity

6. 3.1 Introduction

Previous work by Lo (2000) used point estimates of the transfer coefficients to estimate
the time-dependent compartmental activity. This use of point estimates, while
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computationally more convenient, neglects the uncertainty about the estimates of the
transfer coefficients when calculating the activities. In this portion of the research, a
more rigorous approach was used to estimate the compartmental activity at fixed times.
Specifically, the expected value and standard deviation of compartmental activities were
calculated numerically with quasi-Monte Carlo integration (Wolfram 1996).

6.3.2 Method

The method employed here is based on Box et al. (1965, 1992). Much of their original
notation is used to facilitate reference to the original work. Assuming that observations
of the activity, Yu, are independent, the joint posterior density of the parameters in
proportional form is derived as

II

p(0, AID) oc

IT p(DIO, A)p(0, A)
U=I

Ii

1

oc IAl2 exp{--;_,

~

2

..

LL a' S(0)} p(0. A)

"- l=I

1

(6.6)

/=I

D represents the observation pairs {Yu• tu} for u = ( 1, 2 .... , 10), and S (0) is a 2x2 matrix
containing the sum of squares and sum of products of the deviations between the
observed Yiu's and the expected values aiUu, 0):
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(6.7)

where
n

Si/9)= L[Yiu -aJtu,9)][YJu -a/tu,9)]

(6.8)

u=I

The prior distributions for the parameters are assumed to be independent (i.e. p(0,A) =
p(0)p(A)). Prior distributions for the elements of e are assumed to be proportional to a
constant, and non-informative Jeffrey's priors are used for the elements of A:

p(0) oc constant

The joint posterior density of the parameters in proportional form may then be written as

n-3
1
oc IAIT exp{--tr(AS(9))}

2

(6.9)

tr(A S(0)) is the trace of the 2x2 matrix formed by multiplying A and S(0). Next, the
dependence on A is eliminated using results for the Wishart distribution (Box et al.
1992):
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f IAl 2

n-J

p(9ID) oc

}

exp{- 7 tr(AS(9))}dA

A>O

-

(6.10)

IS(0)1 is the determinant of the "S-matrix" given by Equations 6.6 and 6.7. Marginal
densities for individual parameters were calculated by numerical integration over the
other parameters.

Fits for the compartmental activities were obtained by computing the expected values of
the compartmental activities at different times. The expected value of the activity and the
standard deviation of the expected value in compartment i at time tu are calculated in the
usual manner

E(ai (f ,9))
O

=ff fai (t

0

(6.11)

,9)p(9ID)dadf3dy

rBA

I

SD(ai (I u. 9)) = (

Jf J< ai

(I u. 9)) 2 p(9ID)dad~dy-(E(ai (t O ,

9))) 2 ]

2

(6.12)

rBA

6.3.3 Results

Figures 6.2, 6.3, and 6.4 show the marginal densities for the transfer coefficients. The
fits for the compartmental activities were obtained by calculating the expectation and
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1

standard deviation of the activities from t= 1 until t=S00 (hours). Figure 6.5 show the fit
for the bone surface activity data where the expected values are represented by the solid
line, the expected values ± one standard deviation by the dashed lines, and the original
data by the dots.

Figure 6.6 show the fit for the plasma activity data where the expected values are again
represented by the solid line, the expected values+ one standard deviation by the dashed
lines, and the original observations by the dots.
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400

Figures 6.3 and 6.4 reveal mixed results. The fit of the bone surface activity data is
excellent, all of the original data points lie within one standard deviation of the expected
value. However, the fit of the plasma data is rather poor. Something is wrong with either
the model or with the data. The results provide an opportunity to point out one of the
reasons why compartmental modeling should be conducted with solutions to differential
equations rather than with sums of exponentials. Were the latter approach to be used,
there is no doubt that a "better" fit from a sum of squared errors perspective would result.
The resulting model would be overfit~ subsequent inference would be based on a model
that fit noise rather than one based on the actual dynamics of the system. Using solutions
to the differential equations avoids the problem of overfitting.

6.4 Compartmental Modeling with Missing Observations

6. 4.1 Introduction

The data used in the last section are complete, meaning that there are observations of both
compartmental activities for each observation time. In practice it is not uncommon for
one or more of the observations to be missed during the course of an experiment or
during occupational monitoring. In this section a modification of the general approach of
Box et al. ( 1970) for estimation of missing values in multiresponse nonlinear modeling
was applied to the specific topic of compartmental modeling with missing observations.
The method allows posterior distributions to be derived for not only the transfer
coefficients. but for the missed observations as well.
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6.4.2 Method

This approach below is identical to that used in the last section with the exception that the
missed observations are treated as additional parameters. All of the response data are
represented by y'=(y 1', yz'), where y{ is a 1xn column vector containing all of the
observations for compartment i. The vector y' is rearranged and partitioned into two
parts y0 ' and Ym', where y 0 ' represents the observations actually obtained and Ym' stands
for the parameters representing the missed observations. Again assuming that the
observations are independent, the joint posterior density of the parameters is proportional
form is:

n

p(9, A,y mID)

OC

TI p(Dl9, A,y m)p(9, A, Ym)
u=I

S(0,Ym) is again a 2x2 matrix with elements Sij(0.ym) corresponding to the sum of squares
and sum of products of the deviations between they/sand the expected values ai(tu, 9).

The prior distributions for the parameters are assumed to be independent (i.e. p(0,A,ym) =
p(0)p(A)p(ym)). Prior distributions for the elements of 0 and Ym are assumed to be
proportional to a constant, and non-informative Jeffrey's priors are again used for the
elements of A. Proceeding as in the last section, the dependence on A is eliminated using
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properties of Wishart distributions. The resulting joint posterior density of the
parameters is given by

n

p(9, Ym ID) OC IS(9, Ym f2

(7.5)

Marginal densities for individual parameters were obtained with quasi-Monte Carlo
numerical integration over the other parameters. For the purposes of demonstration, two
examples were considered. In the first, the 71n observation of the bone surface activity.
Yu, was omitted from the

45 Ca

biokinetic data. For the second example, y1.7 and the 81n

observation of plasma activity, Y2.8, were omitted. In each case the observations omitted
were chosen arbitrarily.

6.4. 3 Results

Figures 6.7, 6.8. and 6.9 compare the marginal densities for the transfer coefficients with
1 and 2 observations missing. Figures 6.10 and 6.11. respectively. show the posterior
densities for y1.7 with 1 and 2 missing observations, and for y2 _8 with 2 missing
observations.
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The only figure that shows a significant discrepancy between marginal densities is Figure
6. 7, which reveals that the uncertainty of the posterior density of a actually decreases
when estimated with 1 and 2 missing observations. This may be attributable to the
arbitrarily omitted observations containing a disproportionate amount of measurement
error.

6.5 Discussion

The fit obtained for the plasma specific activity shown in Figure 6.6 and the marginal
densities of a with shown in Figure 6. 7 are indicative of problems with the 45 Ca
biokinetic data. In the first case. a better fit is expected. Even if the expected values do
not agree with the actual data. the uncertainty of the expected values should be more
reflective of the actual data. With respect to Figure 6.7, it was anticipated that
considering less data would result in greater parameter uncertainty; the exact opposite
occurred.

In both sections. more general methods for multiresponse nonlinear fitting were adapted
to compartmental modeling. In Section 6.3. the uncertainty of parameter estimates was
considered when estimating compartmental activities for fixed times, an improvement
over the usual practice of using point estimates. The latter approach ignores all
information about the uncertainty of the parameter estimates. As noted in Section 6.4.1,
there are many reasons why observations may be missed in practice. In Section 6.4 a tool
was developed for estimating the transfer coefficients as well as the missed observations.
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CHAPTER 7: POSTERIOR DENSITIES FOR COMPARTMENT AL
ACTIVITIES

7.1 Introduction

In Chapter 6 expected values and variances were calculated for the time-dependent
compartmental activities of the 45 Ca biokinetic model. This represents an improvement
over the use of point estimates of the activities, but even those results remain
unsatisfactory based on the premise that uncertainty should be described with probability
distributions. This point is made forcefully clear by Lindley (1983) :

''The probability distribution is a complete statement and point or interval estimates, or
significance tests are not necessary. "No estimation problem per se is acknowledged to
exist (de Finetti, 1961 )". Estimates may be calculated - for example. E(0 ID) is a
possible point estimate - but they are derived from the full specification and information
is necessarily lost in using them'".

With this in mind. attempts were made to derive posterior probability distributions for the
compartmental activities at a fixed time tr. Two different approaches were considered.
The first is a reinterpretation of the method used in the Chapter 6 for compartmental
modeling with missing observations. which yields the predictive density for an
observation of the compartmental activity at time tr. The second involves a
transformation of variables using the joint posterior density of the parameters derived as
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in Chapter 6, resulting in a posterior density for the expected value of the compartmental
activity at time tr. The former is always attainable relatively easily, while the latter is not
except for very simple compartmental models. The methods are discussed in the Section
7.2 and demonstrated in Section 7.3. The chapter concludes with a discussion of the
results and a comparison of the two methods in Section 7.4.

7.2 Method

7.2.1 Predictive Density.for a Future Observation ofActivity

Consider a generic m-compartment model with k common parameters denoted by 0={ 0 1,
02, 03, .... Ok}. Let Yu={Ytu, Y2u, Y3u, ... , Ymu} represent observations of the activity
contained in each of the m compartments at time t=tu for u=( 1, 2, ... , n-1 ). It is desired to
obtain posterior densities for observations of the compartmental activities at time t=tr,

I

denoted by p(yr tr, D) where YF{Y1r, Y2r, Y3f, ... , Ymr} and D represents the totality of the
experimental data (Yu and the associated lu for u=(l, 2, ... , n-1)). One means of obtaining

I

p(yr tr, D) is the predictive density, given in general form by

p(y r

jtr. D) oc fL(y r i'I', tr, D) P('l'iD)a\j,
~,
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(7.1)

L(yr I'V, tr ,D) is the likelihood of the observation vector of interest and p('fl ID) is the
joint posterior density of the parameters. This predictive density will now be derived for
a generic compartmental model.

The following response model is assumed for the observed activity in each compartment
at time lu:

ai(/u,0) is the expectation function for the ith compartment obtained by solving the system
of differential equations that describe the movement of activity inside the compartmental
model. It is assumed that the Eiu come from independent multivariate normal
distributions with E(Eiu)=O, E(Eiu Ejv)=O for u;ev, and E(Eiu Eju)=crij. The variance
covariance matrix is again denoted L, and its inverse by A:

and

Letting au={ai(tu,0), az(lu,0), a3(tu,0), ... , <1m(tu,0)} represent the expectation functions
associated with them compartments time

lu,

the likelihood of Yu is given by the

multivariate normal distribution
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(7.2)

The predictive density is derived as follows

p(y f

It

f'

D) oc

ff L(y 10, A,
f

If'

(7.3)

D) p(O, A)D)dAa'O

0A

1
ff TTIAl ! exp{--(y;
-a,)'A(y, -a;)}p(0,A)dAa'9
2
II

oc

(7.4)

2

('>

A

i=I

where the contribution for i=n corresponds to the likelihood of y,. Proceeding as in
Chapters 6, independent uniform priors are chosen for the 0i, Jeffreys priors for A, and
the dependence on A is eliminated using properties of the Wishart distribution. The
following expression for the predictive density results:

p(y

f1,

f,

D) oc

JIS(O. y ff

n

2 dO

(7.5)

('-)

IS (0,yr) I is the determinant of the mxm matrix containing the sum of squares and sum
of products of the deviations between the observed Yiu· s and the expected values ai(tu, 0):
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n

S;/Yr,0)= L[Yiu -ai(tu,O)][yJU -a/tu,O)],

iJ = (L 2, ... , m)

u=I

Marginal posterior densities for the future obsservation of an individual compartment's
activity at time tr, say y I r for example, may be obtained by numerical integration over the
other Yirand 0.

7.2.2 Posterior Density for the F.xpected Value ofActivity

The generic m-compartment model discussed in the previous section will be used again.
Proceeding as in Chapter 6, the following form is obtained for the joint posterior density
of the parameters conditional on the (n-1) timed pairs of observations

n-1

p(0jD) oc

f TT p(Dj9, A)p(O. A)dA
A

u=I

(7.6)

The desired quantity is the posterior density for the expected value of the activity in
compartment i at time tr, denoted p(ai (tr) ID). Using the truncated notation of ai = ai (tr),
a transformation of variables may performed using the standard result from probability
calculus given in Equation 7.7:
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where

The desired quantity, p(ai (tr) ID), is subsequently obtained by numerically integrating out
the

~j-

While a nonzero Jacobian confirms the existence of an inverse function, in the

case of compartmental models the explicit form of the inverse function cannot be
obtained except for a few simple models. Consequently, the marginal posterior density
for the expected value will rarely be attainable. Below a simple 2-compartment catemary
model is considered for which the explicit form of the inverse function can be obtained
for the expected value of the activity in compartment 1.

7.3 Examples

7.3.1 2-Compartment Caternary Model

The method will be demonstrated first with simulated data for the 2-compartment
catemary model shown in Figure 7 .1
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Figure 7.1: 2-compartment catemary model

The activities in compartment 1 and compartment 2 at time tu are denoted a,(tu, a) and
a2(/u, a, 13) respectively. The differential equations describing the movement of activity
through the model are given by

da 1 (t. a) _
(
- - - - - -aa 1 !.a)
dt

da 0 (t.a,l3)

-

dt

= aa 1 (t.a)-l3a,(t.a,l3)
-

(7.8)

(7.9)

Subject to the initial conditions of a 1(0, a)=l and a2(0. a, 13)= 0. the following solutions
were obtained to the system of differential equations
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a 1 (t,a) = exp{-a.t}

(7.10)

A)- a(exp{-a.t}-exp{-l3t})

a.., (t~a,p - - - - - - - - - -

-

(7.11)

13-a

Data were simulated by setting a=0.6 and l3=0.2 in Equations 7.10 and 7.11 and
evaluating for t=0.5:5 in increments of 0.5. Normal noise obtained by random sampling
from a normal distribution with mean zero and standard deviation of 0.05 was then added
to the precise values. The data are plotted in Figure 7.2.
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Figure 7.2: Simulated data for 2-compartment caternary model
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5

A convenient feature of this model is that the expectation function for the activity in
compartment 1 is dependent only on a. permitting derivation of the explicit form of the
inverse of a 1(tu, a). The posterior density for the expected value of the activity in
compartment 1 for a fixed time tr is calculated as follows

(7.12)

where the integration over~ is performed numerically and a(a 1(tr)) is the inverse of a 1
given by

(7.13)

Figure 7.3 shows the resulting posterior density for the expected value of the activity in
compartment 1 along with the predictive density for the observed value of the activity,
both calculated for tr = 3 .25.

It is clear from Figure 7.3 that the predictive density for the observed value shows more
uncertainty, a reflection of the potential measurement error associated with observation.
Clearly. the posterior density of the expected value is a more attractive estimate from the
standpoint of precision. Unfortunately, explicit inverse functions cannot be obtained for
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0.3

more complex models. In such cases. an approximation to the posterior density for the
expected value is best obtained using point estimates of the expectation and variance,
obtained as in Section 6.3, and assuming normality. This approach will be used for the
remainder of this chapter.

The posterior density for the activity in compartment 2 at time tr= 3.25 is examined next.
Figure 7.4 shows a comparison of the predictive density for the observed activity in
compartment 2 a time t=3.25 and the associated posterior density for the expected value
calculated with an assumption of normality.

The results again show a pronounced difference between the uncertainties of the
densities. It is also notable that the predictive densities in Figures 7 .3 and 7.4 appear to
have a normal shape with the same mode as the posterior density for the expected value,
and a greater variance.
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7.3.2 2-compartment 45 Ca model

To avoid unnecessary repetition the reader is referred to Section 6.2 for the specifics of
the 45 Ca biokinetic model and the associated data. Predictive densities were derived for
the observed activity at the bone surface and in the plasmas for IF100 (hours). Figure 7.5
shows the predictive density of the observed value and the posterior density of the
expected value for bone surface activity. The latter was calculated under the assumption
of normality.

In Figure 7 .5 the discrepancy between the two probability densities is less pronounced
than for the catemary model considered earlier. It is thought that this is a reflection of the
excellent fit of the bone surface activity (Chapter 6, Figure 6.5). Figure 7.6 shows the
predictive density of the observed value and the posterior density of the expected value
for plasma activity at tFl 00 (hours). The latter was again calculated under the
assumption of normality.

In this case there is a large discrepancy between the two probability densities. The
degree of the discrepancy is such that the predictive density is truncated to make the
posterior density for the expected value visible. The complete predictive density is
shown in Figure 7.7.
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The disagreement between the two densities is understandable when one considers the
poor fit obtained for the plasma data (Chapter 6, Figure 6.6).

7.4 Discussion

In this chapter the calculation of probability densities for compartmental activities was
considered. It was shown that while the posterior density for the expected value is
typically a more desirable description of compartmental activity at a fixed time, it is
directly attainable only in simple cases when the inverse of the expectation function can
be explicitly obtained. Otherwise, the suggestion is to use an assumption of normality
and the point estimates for the expected value and variance of the compartmental activity
or the more diffuse predictive density for the observed value of the activity.
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CHAPTER 8: CONCLUSIONS, ORIGINAL CONTRIBUTIONS, AND
RECOMMENDATIONS FOR FUTURE WORK

8.1 Conclusions and Original Contributions

The objective of this research was to provide original solutions to several problems in
external and internal radiation dosimetry from a Bayesian standpoint. The rationale for a
Bayesian standpoint was discussed in Chapter 1. The discussion considered not only the
advantages of a Bayesian approach as compared to frequentist alternatives, but also the
potential computational difficulties. The point was made that current steady increase in
the availability of computing power is mitigating the computational burden. The specific
original accomplishments in radiation dosimetry include the following:

1. The work of Groer et al. ( 1987) for dose estimation with chromosome dosimetry was
expanded to different models and radiation types. Several new calibration data sets and
dose response models were considered: response to gamma rays and low doses of
neutrons. In each case posterior densities were derived for the parameters of dose
response models and the calibrative density was used to quantify the uncertainty of dose
estimates made following hypothetical radiation exposures. The parameter and dose
estimates were found with reasonable computational effort, reinforcing the practicality of
Bayesian methods for chromosome dosimetry.
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2. A new method was derived and demonstrated for dose estimation with chromosome
aberrations following a criticality event. Because the doses received during a criticality
event are from a combination of fission spectrum neutrons and gamma rays, the dose
estimation process is more complex than for doses deposited by a single type of radiation.
The method permits estimation of the total dose, as well as the contributions from
neutrons and gamma rays. The method is an improvement over the frequentist methods
currently in use as it permits an uncertain neutron to gamma dose ratio. Analytical results
were provided for intermediate expressions, minimizing the computational burden of
subsequent analyses.

3. An original method was developed and demonstrated for chromosome dosimetry that
considers the inherent uncertainty of the doses in controlled calibration experiments. The
fact that all doses in calibration experiments are to some degree imprecise estimates is
obvious. The approach was demonstrated for three different dose response models:
linear dependence on dose with no background term, linear dependence on dose with a
background term, and linear-quadratic dependence on dose with a background term. This
approach and the simplified intermediate expressions provide a coherent means of
accounting for uncertain calibration doses with minimal computational effort.

4. A new model, the Polya or negative binomial model, was considered for chromosome
dosimetry with high LET radiations. The occurrence of overdispersion for high LET
radiations violates the standard assumption of a Poisson model. The Bayes Factor was
used to show that the Polya or negative binomial model is a better choice for high LET
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radiations. In addition to model comparison, posterior densities for the parameters and
calibrative densities were calculated for two calibration data sets under the assumption of
a Polya model. The use of the Polya model and the calibrative density is an original and
clear improvement over the current practice of retaining the Poisson model and ad-hoc
adjustments based on estimates for the variance/mean ratio.

5. The expected values and associated standard deviations of the specific activity at the
bone surface and in the plasma were calculated for the

45 Ca

biokinetic compartmental

model using the data of Rowland et al. (1960). This was a continuation of the work of Lo
(2000) but with increased computing power. Calculation of expected values and standard
deviations with numerical integration is an improvement on the use of point estimates of
the transfer coefficients to estimate time-dependent compartmental activities.

6. The general method of Box et al. (I 970) for dealing with missing observations in
nonlinear multiresponse modeling was adopted for compartmental modeling. There are
many reasons why observations may be missed in practice; the method demonstrated in
Chapter 6 is a coherent means of imputing the missed observations using all available
data. The method was demonstrated for one and two missed observations with the

45 Ca

data of Rowland et al. (1960).

7. In recognition of the Bayesian notion that the probability distribution is the best
descriptor of an unknown quantity, two new and different approaches were taken to
deriving posterior densities for the compartmental activity at a fixed time. The first
124

approach is a reinterpretation of the method of Box et al. (1970) for dealing with missing
observations in nonlinear multiresponse modeling, and yields the predictive density for
an observation of the activity. The second method considered is based on a
transformation of random variables approach, and yields the posterior density for the
expected value of the activity. The predictive density was found to be computable in all
cases, but is less desirable since it always shows greater uncertainty. The posterior
density for the expected value was found to be computable only for extremely simple
compartmental models.

In summary, eight new applications of Bayesian methods were developed and applied to
problems in internal and external radiation dosimetry. Each application addressed a
specific deficiency in current practices. The totality ofthis effort shows that a Bayesian
approach is a practical alternative to the frequentist approaches used in radiation
dosimetry.

8.2 Recommendations for Future Work

With respect to external radiation dosimetry, more work can be done on the topic of
chromosome dosimetry following criticality accidents. The examples considered in this
research were based on limited data. More analyses should be conducted with more
expansive calibration data sets. On the larger front, future work should focus on fostering
wider acceptance and use of the calibrative density for dose estimation. The calibrative
density has several novel and desirable features that represent an improvement over the
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methods currently being used for dose estimation. Specifically, the calibrative density
permits information from diverse sources to be incorporated in the dose estimation
process in a formal and coherent manner, and yields results that describes uncertainty
probabilistically

For internal radiation dosimetry, future work should continue on two fronts, one
computational and the other experimental. On the computational front, more complex
models will require increased computing power and the use of novel numerical routines
for combining solutions of systems of differential equations and multi-dimensional
numerical integration. A specific area of focus should be numerical methods for
performing the transformation of variables discussed in Chapter 7. On the experimental
front, there is a pronounced lack of data on individual compartmental activities. The
reason for this is twofold: difficulty in collecting data for individual compartments and
the widespread acceptance of regression techniques that do not require data on each
compartment. Progress on this front will come in response to perceived need; the case
must be made in practical situations, like nuclear medicine, for estimation of transfer
coefficients and time-dependent compartmental activities with solutions to the system of
differential equations instead of regression techniques.
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See attached CD ROM (plate I) for Appendix material

The CD contains Mathematica code (version 4.0, Student Edition) used in this
dissertation. The code is contained in a Mathematica notebook named "appendix.nb".
The contents of the notebook are arranged according to chapter and topic in the
dissertation.
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